Last updated: 4 months ago
Lexaria Bioscience Corp Financial Report: Insights & Stock Recommendation
Explore Lexaria Bioscience Corp's latest financial report highlighting a 21.6% revenue increase, $2.7M net loss, and a 'Hold' stock recommendation amid concentration risks.